This protocol is judged by an institutional evaluate board, an impartial group that testimonials any medical trials involving people. If a study involves a Schedule I drug, once the board approves the protocol as moral, the researchers really need to apply for an investigational new drug (IND) quantity in the FDA.The good thing is, other businesses